| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 37.51B | 38.74B | 40.42B | 39.19B | 31.78B | 30.55B |
| Gross Profit | 10.11B | 9.96B | 8.29B | 8.90B | 7.00B | 6.30B |
| EBITDA | 5.82B | 5.86B | 1.86B | 3.89B | 3.18B | 2.75B |
| Net Income | 3.17B | 3.16B | -1.85B | 1.56B | 726.00M | 742.00M |
Balance Sheet | ||||||
| Total Assets | 40.24B | 40.41B | 39.96B | 41.61B | 37.41B | 34.91B |
| Cash, Cash Equivalents and Short-Term Investments | 4.79B | 5.12B | 4.08B | 2.86B | 3.05B | 4.02B |
| Total Debt | 6.20B | 7.74B | 9.80B | 10.79B | 8.32B | 8.57B |
| Total Liabilities | 14.63B | 15.04B | 17.69B | 19.36B | 16.84B | 16.04B |
| Stockholders Equity | 20.85B | 20.69B | 18.19B | 19.10B | 18.08B | 16.79B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 3.77B | 2.64B | -2.70B | -285.00M | 2.23B |
| Operating Cash Flow | 0.00 | 5.18B | 4.91B | -540.00M | 1.04B | 3.51B |
| Investing Cash Flow | 0.00 | -1.18B | -3.02B | -1.50B | -1.32B | -897.00M |
| Financing Cash Flow | 0.00 | -2.55B | -1.61B | 1.82B | -762.00M | -31.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥84.63B | 11.63 | 15.07% | 1.74% | 15.12% | 40.72% | |
80 Outperform | ¥21.89B | 9.84 | ― | 1.82% | -7.26% | ― | |
75 Outperform | ¥55.20B | 16.36 | ― | 2.92% | 3.03% | 28.27% | |
70 Outperform | ¥58.51B | -468.17 | ― | 4.37% | -1.09% | ― | |
67 Neutral | ¥802.55B | 77.75 | -2.50% | 3.49% | -6.83% | -123.67% | |
62 Neutral | ¥94.24B | 19.44 | ― | 1.30% | 47.56% | 49.58% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |